28877763|t|Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
28877763|a|The pathology of Alzheimer's disease (AD) is characterized by dystrophic neurites (DNs) surrounding extracellular Abeta-plaques, microgliosis, astrogliosis, intraneuronal tau hyperphosphorylation and aggregation. We have previously shown that inhibition of the spleen tyrosine kinase (Syk) lowers Abeta production and tau hyperphosphorylation in vitro and in vivo. Here, we demonstrate that Abeta-overexpressing Tg PS1/APPsw, Tg APPsw mice, and tau overexpressing Tg Tau P301S mice exhibit a pathological activation of Syk compared to wild-type littermates. Syk activation is occurring in a subset of microglia and is age-dependently increased in Abeta-plaque-associated dystrophic neurites of Tg PS1/APPsw and Tg APPsw mice. In Tg Tau P301S mice, a pure model of tauopathy, activated Syk occurs in neurons that show an accumulation of misfolded and hyperphosphorylated tau in the cortex and hippocampus. Interestingly, the tau pathology is exacerbated in neurons that display high levels of Syk activation supporting a role of Syk in the formation of tau pathological species in vivo. Importantly, human AD brain sections show both pathological Syk activation in DNs around Abeta deposits and in neurons immunopositive for pathological tau species recapitulating the data obtained in transgenic mouse models of AD. Additionally, we show that Syk overexpression leads to increased tau accumulation and promotes tau hyperphosphorylation at multiple epitopes in human neuron-like SH-SY5Y cells, further supporting a role of Syk in the formation of tau pathogenic species. Collectively, our data show that Syk activation occurs following Abeta deposition and the formation of tau pathological species. Given that we have previously shown that Syk activation also promotes Abeta formation and tau hyperphosphorylation, our data suggest that AD pathological lesions may be self-propagating via a Syk dependent mechanism highlighting Syk as an attractive therapeutic target for the treatment of AD.
28877763	0	40	Alzheimer's disease pathological lesions	Disease	MESH:D000544
28877763	54	76	spleen tyrosine kinase	Gene	20963
28877763	95	114	Alzheimer's disease	Disease	MESH:D000544
28877763	116	118	AD	Disease	MESH:D000544
28877763	140	159	dystrophic neurites	Disease	MESH:D058225
28877763	161	164	DNs	Disease	MESH:D058225
28877763	192	197	Abeta	Gene	351
28877763	207	219	microgliosis	Disease	
28877763	221	233	astrogliosis	Disease	MESH:D005911
28877763	249	252	tau	Gene	4137
28877763	339	361	spleen tyrosine kinase	Gene	20963
28877763	363	366	Syk	Gene	20963
28877763	375	380	Abeta	Gene	14961
28877763	396	399	tau	Gene	4137
28877763	469	474	Abeta	Gene	14961
28877763	493	496	PS1	Gene	19164
28877763	513	517	mice	Species	10090
28877763	523	526	tau	Gene	4137
28877763	545	548	Tau	Gene	4137
28877763	549	554	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
28877763	555	559	mice	Species	10090
28877763	597	600	Syk	Gene	20963
28877763	636	639	Syk	Gene	20963
28877763	725	730	Abeta	Gene	14961
28877763	749	768	dystrophic neurites	Disease	MESH:D058225
28877763	775	778	PS1	Gene	19164
28877763	798	802	mice	Species	10090
28877763	810	813	Tau	Gene	4137
28877763	814	819	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
28877763	820	824	mice	Species	10090
28877763	842	851	tauopathy	Disease	MESH:D024801
28877763	863	866	Syk	Gene	20963
28877763	948	951	tau	Gene	4137
28877763	1002	1005	tau	Gene	4137
28877763	1070	1073	Syk	Gene	20963
28877763	1106	1109	Syk	Gene	6850
28877763	1130	1146	tau pathological	Disease	MESH:C536599
28877763	1177	1182	human	Species	9606
28877763	1183	1185	AD	Disease	MESH:D000544
28877763	1224	1227	Syk	Gene	6850
28877763	1242	1245	DNs	Disease	MESH:D058225
28877763	1253	1258	Abeta	Gene	351
28877763	1315	1318	tau	Gene	4137
28877763	1374	1379	mouse	Species	10090
28877763	1390	1392	AD	Disease	MESH:D000544
28877763	1421	1424	Syk	Gene	6850
28877763	1459	1462	tau	Gene	4137
28877763	1489	1492	tau	Gene	4137
28877763	1538	1543	human	Species	9606
28877763	1556	1563	SH-SY5Y	CellLine	CVCL:0019
28877763	1600	1603	Syk	Gene	6850
28877763	1624	1627	tau	Gene	4137
28877763	1681	1684	Syk	Gene	20963
28877763	1713	1718	Abeta	Gene	351
28877763	1751	1767	tau pathological	Disease	MESH:C536599
28877763	1818	1821	Syk	Gene	20963
28877763	1847	1852	Abeta	Gene	351
28877763	1867	1870	tau	Gene	4137
28877763	1915	1938	AD pathological lesions	Disease	MESH:D000544
28877763	1969	1972	Syk	Gene	20963
28877763	2006	2009	Syk	Gene	6850
28877763	2067	2069	AD	Disease	MESH:D000544
28877763	Association	MESH:D024801	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
28877763	Association	MESH:D058225	4137
28877763	Association	MESH:D000544	6850
28877763	Association	351	6850
28877763	Association	14961	19164
28877763	Association	MESH:D058225	20963
28877763	Positive_Correlation	4137	6850
28877763	Association	MESH:C536599	6850
28877763	Positive_Correlation	20963	351
28877763	Association	MESH:D058225	14961
28877763	Positive_Correlation	14961	20963
28877763	Association	MESH:D000544	351
28877763	Association	MESH:D000544	4137
28877763	Positive_Correlation	19164	20963
28877763	Association	MESH:D058225	351
28877763	Association	MESH:D000544	20963
28877763	Association	MESH:D024801	20963
28877763	Positive_Correlation	20963	4137
28877763	Association	MESH:D058225	6850
28877763	Association	MESH:C536599	20963
28877763	Association	MESH:D024801	4137

